PROFESSOR MEDICAL ACADEMIC CENTRE

CLINICAL

BIOCHEMISTRY

GLOSSARY TERMS

Short Notes for Medical and Paramedical Students

SECTION -V

A Quick Reference Guide for Undergraduate Medical Students, Postgraduate Medical Students, and Paramedical Students.

DR.C.GANESAN M.D

PROFESSOR OF MEDICINE

CLINICAL

BIOCHEMISTRY

GLOSSARY TERMS

SECTION V – LIPID METABOLISM

Chapter 48: Digestion and Absorption of Lipids

01. Lipid
Lipids are water-insoluble biological molecules that serve as energy stores and structural components of cells. They include triglycerides, phospholipids, and cholesterol. Dietary lipids must be digested before absorption. They provide concentrated energy for the body. Lipid metabolism is essential for growth and survival.

02. Dietary Fat
Dietary fat is the lipid consumed through food sources such as oils, dairy products, and meat. Most dietary fat consists of triglycerides. Digestion begins in the gastrointestinal tract. Absorbed fats provide energy and essential fatty acids. Excess fat is stored in adipose tissue.

03. Triglyceride
Triglycerides are molecules composed of glycerol and three fatty acids. They are the major form of dietary and stored fat. Digestive enzymes hydrolyze them into absorbable products. They provide a rich source of metabolic energy. Excess triglycerides are stored in adipose tissue.

04. Phospholipid
Phospholipids are membrane lipids containing fatty acids and a phosphate group. They contribute to cell membrane structure. Digestion is mainly carried out by phospholipase enzymes. Their products are absorbed by intestinal cells. They are important for membrane integrity and signaling.

05. Cholesterol Ester
Cholesterol esters are cholesterol molecules linked to fatty acids. They are present in dietary lipids and lipoproteins. Cholesterol esterase hydrolyzes them during digestion. Free cholesterol is then absorbed by enterocytes. They play a role in cholesterol transport and storage.

06. Emulsification
Emulsification is the breakdown of large fat droplets into smaller droplets. Bile salts facilitate this process in the intestine. It increases the surface area available for enzyme action. Efficient digestion depends on proper emulsification. It is a crucial step in lipid absorption.

07. Bile Salt
Bile salts are amphipathic molecules produced from cholesterol in the liver. They emulsify dietary fats in the intestine. They aid micelle formation and lipid absorption. Most bile salts are reabsorbed and recycled. They are essential for normal fat digestion.

08. Bile Acid
Bile acids are synthesized from cholesterol in the liver. They are converted into bile salts before secretion. They facilitate digestion and absorption of lipids. Enterohepatic circulation conserves bile acids efficiently. Deficiency may impair fat absorption.

09. Mixed Micelle
Mixed micelles are microscopic aggregates containing bile salts and lipid digestion products. They transport lipids across the intestinal lumen. Fatty acids and monoglycerides are carried to enterocytes. Micelles enhance lipid absorption efficiency. They are essential for transporting hydrophobic molecules.

10. Pancreatic Lipase
Pancreatic lipase is the major enzyme responsible for triglyceride digestion. It hydrolyzes triglycerides into monoglycerides and fatty acids. The enzyme acts in the small intestine. Colipase assists its attachment to lipid droplets. It is vital for normal fat digestion.

11. Colipase
Colipase is a protein cofactor secreted by the pancreas. It helps pancreatic lipase bind to emulsified fats. Its action is important in the presence of bile salts. It enhances lipid hydrolysis efficiency. Deficiency may impair fat digestion.

12. Phospholipase A₂
Phospholipase A₂ hydrolyzes phospholipids during digestion. It releases fatty acids and lysophospholipids. The enzyme is secreted by the pancreas. Its activity contributes to phospholipid absorption. It supports complete digestion of dietary lipids.

13. Cholesterol Esterase
Cholesterol esterase hydrolyzes cholesterol esters into free cholesterol and fatty acids. It acts in the intestinal lumen. The enzyme facilitates cholesterol absorption. It also acts on other lipid esters. Proper activity supports efficient lipid digestion.

14. Lingual Lipase
Lingual lipase is secreted by glands of the tongue. It initiates fat digestion in the mouth and stomach. The enzyme is particularly important in infants. It acts mainly on short-chain triglycerides. Its activity continues in acidic gastric conditions.

15. Gastric Lipase
Gastric lipase is produced by gastric mucosal cells. It contributes to triglyceride digestion in the stomach. The enzyme functions in acidic environments. It complements pancreatic lipase activity. Its role is significant during infancy.

16. Duodenum
The duodenum is the first segment of the small intestine. It receives bile and pancreatic secretions. Most lipid digestion occurs within this region. Enzymatic breakdown of fats is initiated here. It plays a central role in nutrient absorption.

17. Jejunum
The jejunum is the principal site of nutrient absorption. Lipid digestion products are absorbed through its mucosa. Enterocytes process absorbed fatty acids and monoglycerides. Efficient nutrient uptake occurs here. It is vital for maintaining nutritional status.

18. Enterocyte
Enterocytes are absorptive epithelial cells lining the small intestine. They take up lipid digestion products from micelles. Re-esterification occurs within these cells. Chylomicrons are formed before lipid transport. They are essential for nutrient absorption.

19. Fat Digestion
Fat digestion is the enzymatic breakdown of dietary lipids. It begins in the stomach and continues in the intestine. Lipases hydrolyze triglycerides into absorbable components. Bile salts facilitate the process. Proper digestion is necessary for lipid utilization.

20. Lipid Absorption
Lipid absorption is the uptake of digested fats by enterocytes. Micelles deliver lipid molecules to intestinal cells. Lipids are reassembled and packaged into chylomicrons. They enter lymphatic circulation for transport. Efficient absorption supports energy metabolism.

21. Monoglyceride
Monoglycerides contain glycerol linked to one fatty acid. They are products of triglyceride digestion. Micelles transport them to enterocytes. They are re-esterified within intestinal cells. They contribute to triglyceride resynthesis.

22. Free Fatty Acid
Free fatty acids are released during lipid digestion. They are absorbed from micelles into enterocytes. Inside cells, they undergo re-esterification. They serve as important energy substrates. Excess fatty acids may be stored as triglycerides.

23. Chylomicron
Chylomicrons are large lipoproteins formed in intestinal cells. They transport dietary triglycerides and cholesterol. They enter lymphatic vessels before reaching blood circulation. Their primary function is lipid delivery to tissues. They represent the first transport form of dietary fat.

24. Apolipoprotein B-48
Apolipoprotein B-48 is the structural protein of chylomicrons. It is synthesized by enterocytes. It is essential for chylomicron assembly and secretion. The protein facilitates lipid transport. Its absence causes defective lipid absorption.

25. Lacteal
Lacteals are specialized lymphatic vessels within intestinal villi. They absorb chylomicrons after lipid processing. Lipids enter the lymphatic system through these vessels. Lacteals bypass the portal circulation initially. They are crucial for dietary fat transport.

26. Lymphatic Transport
Lymphatic transport carries chylomicrons from the intestine to the bloodstream. It prevents immediate hepatic metabolism of dietary fats. Lipids reach systemic circulation efficiently. The thoracic duct empties lymph into venous blood. This pathway is unique for long-chain fats.

27. Re-esterification
Re-esterification is the process of rebuilding triglycerides inside enterocytes. Absorbed fatty acids combine with monoglycerides. Newly formed triglycerides are packaged into chylomicrons. This step prepares lipids for transport. It is essential for efficient fat absorption.

28. Fat Malabsorption
Fat malabsorption occurs when lipid digestion or absorption is impaired. Causes include pancreatic disease and bile deficiency. Nutritional deficiencies may develop. Patients often pass excess fat in stool. Early diagnosis improves outcomes.

29. Steatorrhea
Steatorrhea refers to excessive fat in feces. It results from defective lipid digestion or absorption. Stools become bulky, pale, and greasy. Nutrient deficiencies may accompany the condition. It is an important clinical sign of malabsorption.

30. Micellar Solubilization
Micellar solubilization is the incorporation of lipid digestion products into micelles. This process increases lipid transport through the intestinal lumen. Bile salts play a central role. It enhances absorption of hydrophobic molecules. Efficient micellar formation is essential for normal lipid uptake.

Chapter 49: Fatty Acid Oxidation

01. Fatty Acid Oxidation
Fatty acid oxidation is the process by which fatty acids are broken down to produce energy. It occurs mainly in mitochondria. Acetyl-CoA, NADH, and FADH₂ are generated. These products enter energy-producing pathways. It is a major source of ATP during fasting.

02. Beta Oxidation
Beta oxidation is the principal pathway of fatty acid degradation. Fatty acids are shortened by two carbon atoms per cycle. Acetyl-CoA is released repeatedly. NADH and FADH₂ are produced for ATP synthesis. This pathway provides substantial metabolic energy.

03. Alpha Oxidation
Alpha oxidation is a specialized pathway for branched-chain fatty acids. It occurs mainly in peroxisomes. The process removes one carbon atom at a time. It is important for phytanic acid metabolism. Defects cause metabolic disorders.

04. Omega Oxidation
Omega oxidation occurs in the endoplasmic reticulum. It oxidizes the terminal carbon of fatty acids. This pathway becomes important when beta oxidation is impaired. Dicarboxylic acids are produced. It serves as an alternative metabolic route.

05. Acyl-CoA
Acyl-CoA is the activated form of a fatty acid. Activation occurs before oxidation begins. Coenzyme A attaches to the fatty acid molecule. It enters metabolic pathways efficiently. Acyl-CoA is essential for lipid catabolism.

06. Carnitine
Carnitine is a transport molecule required for long-chain fatty acid entry into mitochondria. It binds activated fatty acids. The carnitine shuttle carries them across mitochondrial membranes. Adequate carnitine is necessary for energy production. Deficiency impairs fatty acid oxidation.

07. Carnitine Shuttle
The carnitine shuttle transports long-chain fatty acids into mitochondria. It involves specific carrier proteins and enzymes. Fatty acids cross otherwise impermeable membranes. Oxidation occurs after transport is complete. This mechanism is crucial for lipid energy production.

08. Carnitine Acyltransferase I
Carnitine acyltransferase I is located on the outer mitochondrial membrane. It transfers acyl groups to carnitine. This is the first step of mitochondrial fatty acid transport. The enzyme regulates fatty acid entry. Malonyl-CoA inhibits its activity.

09. Carnitine Acyltransferase II
Carnitine acyltransferase II is located on the inner mitochondrial membrane. It reconverts acylcarnitine into acyl-CoA. The regenerated acyl-CoA enters beta oxidation. The enzyme completes fatty acid transport. Deficiency can cause muscle weakness and hypoglycemia.

10. Acylcarnitine
Acylcarnitine is formed when a fatty acid is attached to carnitine. It serves as the transport form of long-chain fatty acids. The molecule crosses the mitochondrial membrane efficiently. Inside mitochondria, it is converted back to acyl-CoA. This process supports fatty acid oxidation.

11. Mitochondria
Mitochondria are the primary sites of beta oxidation. They convert fatty acids into usable cellular energy. Acetyl-CoA, NADH, and FADH₂ are generated here. These products fuel ATP synthesis. Mitochondria are often called the powerhouses of the cell.

12. Peroxisome
Peroxisomes are organelles involved in fatty acid metabolism. They oxidize very long-chain fatty acids. The products are further processed in mitochondria. Peroxisomal oxidation generates hydrogen peroxide. They play an important role in lipid homeostasis.

13. FADH₂
FADH₂ is a reduced coenzyme produced during fatty acid oxidation. It donates electrons to the electron transport chain. ATP is generated through oxidative phosphorylation. Each molecule contributes significantly to energy production. It is an important carrier of metabolic energy.

14. NADH
NADH is produced during oxidation reactions in beta oxidation. It carries high-energy electrons to mitochondria. These electrons drive ATP formation. NADH is a major source of cellular energy. It links fatty acid metabolism with respiration.

15. Acetyl-CoA
Acetyl-CoA is the major end product of beta oxidation. It enters the citric acid cycle for further energy production. Excess acetyl-CoA can be converted into ketone bodies. It is a central metabolic intermediate. Many biochemical pathways depend on it.

16. Thiolase
Thiolase is an enzyme involved in the final step of beta oxidation. It cleaves the fatty acid chain to release acetyl-CoA. The remaining fatty acid continues oxidation. This reaction repeats until complete degradation occurs. Thiolase is essential for energy extraction from fats.

17. Enoyl-CoA Hydratase
Enoyl-CoA hydratase catalyzes the hydration step of beta oxidation. Water is added across a double bond. This prepares the molecule for further oxidation. The enzyme functions within mitochondria. It is a key component of the beta oxidation cycle.

18. Dehydrogenase
Dehydrogenases are enzymes that remove hydrogen atoms from substrates. They generate NADH or FADH₂ during oxidation. These coenzymes carry electrons for ATP production. Multiple dehydrogenases participate in beta oxidation. They are vital for energy metabolism.

19. Ketogenesis
Ketogenesis is the formation of ketone bodies from acetyl-CoA. It occurs mainly in liver mitochondria. The process becomes active during fasting and diabetes. Ketones provide alternative fuel for tissues. It helps conserve glucose during starvation.

20. ATP Production
ATP production is the ultimate purpose of fatty acid oxidation. Electrons generated from oxidation enter the respiratory chain. Oxidative phosphorylation synthesizes ATP. Fatty acids yield more ATP than carbohydrates. This makes them efficient energy stores.

21. Long-Chain Fatty Acid
Long-chain fatty acids contain 12–20 carbon atoms. They require the carnitine shuttle for mitochondrial entry. These fatty acids are abundant in dietary fats. Beta oxidation generates large amounts of ATP. They serve as major metabolic fuels.

22. Medium-Chain Fatty Acid
Medium-chain fatty acids contain 6–12 carbon atoms. They enter mitochondria without the carnitine shuttle. Oxidation occurs rapidly. They provide a quick energy source. Medium-chain triglycerides are used therapeutically in some disorders.

23. Very Long-Chain Fatty Acid
Very long-chain fatty acids contain more than 22 carbon atoms. Initial oxidation occurs in peroxisomes. Shortened products are transferred to mitochondria. Their metabolism is essential for cellular health. Defects cause serious neurological disorders.

24. Fatty Acid Activation
Fatty acid activation converts free fatty acids into acyl-CoA. This reaction requires ATP and coenzyme A. Activation occurs before oxidation begins. It prepares fatty acids for metabolic processing. The reaction takes place in the cytosol.

25. Oxidative Energy Metabolism
Oxidative energy metabolism refers to ATP generation through oxidation of fuels. Fatty acids are major substrates for this process. Electrons pass through the respiratory chain. Large quantities of ATP are produced. It sustains cellular activities during fasting.

26. Carnitine Deficiency
Carnitine deficiency impairs transport of fatty acids into mitochondria. Beta oxidation becomes inefficient. Patients may develop muscle weakness and hypoglycemia. Energy production decreases significantly. Treatment often includes carnitine supplementation.

27. MCAD Deficiency
MCAD deficiency is a disorder of medium-chain fatty acid oxidation. The enzyme defect prevents efficient energy production. Hypoglycemia develops during fasting. Fat accumulation may occur in tissues. Early diagnosis reduces complications.

28. Energy Yield
Energy yield refers to ATP produced from fatty acid oxidation. Long-chain fatty acids generate large amounts of ATP. Palmitate oxidation yields over 100 ATP molecules. This efficiency makes fats ideal energy reserves. Energy yield exceeds that of carbohydrates.

29. Lipolysis
Lipolysis is the breakdown of stored triglycerides into fatty acids and glycerol. It occurs mainly in adipose tissue. Released fatty acids enter circulation. They are oxidized to generate energy. Hormones regulate the rate of lipolysis.

30. Metabolic Fuel
Metabolic fuels are substances used to generate energy. Fatty acids are major fuels during fasting. They provide sustained ATP production. Different tissues utilize them according to metabolic needs. Efficient fuel utilization is essential for survival.

Chapter 50: Ketone Body Metabolism

01. Ketone Body
Ketone bodies are water-soluble molecules produced from fatty acids. The three major ketone bodies are acetoacetate, beta-hydroxybutyrate, and acetone. They serve as alternative energy sources. Production increases during fasting and diabetes. They help conserve glucose.

02. Ketogenesis
Ketogenesis is the synthesis of ketone bodies in liver mitochondria. It occurs when acetyl-CoA accumulates. Fatty acid oxidation supplies the acetyl-CoA substrate. Ketones are released into circulation. They provide fuel for extrahepatic tissues.

03. Ketolysis
Ketolysis is the utilization of ketone bodies by peripheral tissues. Ketones are converted back into acetyl-CoA. The acetyl-CoA enters the citric acid cycle. Energy is produced efficiently. The liver cannot perform ketolysis.

04. Acetoacetate
Acetoacetate is the first ketone body formed during ketogenesis. It can be converted into beta-hydroxybutyrate or acetone. Peripheral tissues utilize it as fuel. Its concentration rises during fasting. It contributes to energy homeostasis.

05. Beta-Hydroxybutyrate
Beta-hydroxybutyrate is the most abundant circulating ketone body. It is produced from acetoacetate. Many tissues utilize it efficiently for energy. It crosses the blood-brain barrier readily. Its level rises markedly during prolonged fasting.

06. Acetone
Acetone is a volatile ketone body formed from acetoacetate. It is excreted mainly through the lungs. A fruity breath odor may occur in ketoacidosis. Acetone contributes little to energy production. It serves mainly as a byproduct.

07. Liver Mitochondria
Liver mitochondria are the primary sites of ketone body production. They convert excess acetyl-CoA into ketones. Ketogenesis occurs predominantly during fasting. The liver exports ketones to other tissues. This supports systemic energy needs.

08. HMG-CoA Synthase
HMG-CoA synthase is the rate-limiting enzyme of ketogenesis. It combines acetyl-CoA molecules to form HMG-CoA. The enzyme is highly active in liver mitochondria. Its activity increases during fasting. It is essential for ketone production.

09. HMG-CoA Lyase
HMG-CoA lyase converts HMG-CoA into acetoacetate. This reaction is a key step in ketogenesis. The enzyme functions in liver mitochondria. Deficiency causes impaired ketone formation. Normal activity supports energy adaptation.

10. Ketonemia
Ketonemia refers to elevated ketone bodies in blood. It occurs during fasting, diabetes, and ketogenic diets. Mild ketonemia is a normal adaptation. Severe elevation may indicate pathology. Monitoring helps assess metabolic status.

11. Ketonuria
Ketonuria is the presence of ketone bodies in urine. It reflects increased ketone production. It commonly occurs during prolonged fasting. Diabetes mellitus is another important cause. Urine testing helps detect metabolic disturbances.

12. Diabetic Ketoacidosis
Diabetic ketoacidosis is a serious complication of insulin deficiency. Excessive ketone production causes metabolic acidosis. Hyperglycemia and dehydration are prominent features. Immediate treatment is required. It is a medical emergency.

13. Starvation Ketosis
Starvation ketosis develops during prolonged fasting. Fatty acid oxidation increases significantly. Ketone bodies become major energy sources. Brain utilization of ketones rises progressively. This adaptation conserves body protein.

14. Ketogenic Diet
A ketogenic diet is high in fat and low in carbohydrates. It promotes ketone body production. The diet is used in certain neurological disorders. Fat becomes the primary energy source. Ketosis develops as a physiological response.

15. Acetyl-CoA Excess
Acetyl-CoA excess occurs when production exceeds citric acid cycle capacity. Excess acetyl-CoA is diverted into ketogenesis. This situation commonly arises during fasting. Ketone bodies are subsequently produced. It represents metabolic adaptation.

16. Hepatic Ketogenesis
Hepatic ketogenesis refers to ketone production by the liver. The liver converts fatty acid-derived acetyl-CoA into ketones. These molecules are exported to other organs. Production increases during glucose scarcity. It supports energy balance.

17. Peripheral Utilization
Peripheral utilization is the consumption of ketone bodies by tissues outside the liver. Muscles and the brain use ketones efficiently. Ketones are converted into acetyl-CoA. ATP is subsequently generated. This conserves glucose stores.

18. Brain Adaptation
Brain adaptation occurs during prolonged fasting. The brain increasingly utilizes ketone bodies. Dependence on glucose decreases. Protein breakdown is reduced. This adaptation improves survival during starvation.

19. Alternative Fuel
Ketone bodies act as alternative fuels when glucose availability is limited. They provide energy to many tissues. Utilization increases during fasting. Alternative fuel use preserves glucose. This mechanism supports metabolic flexibility.

20. Fasting Metabolism
Fasting metabolism involves metabolic changes during food deprivation. Glycogen stores become depleted. Fatty acid oxidation and ketogenesis increase. Ketones become major energy sources. These adaptations maintain energy supply.

21. Insulin Deficiency
Insulin deficiency promotes lipolysis and ketogenesis. Fatty acids are released from adipose tissue. Liver ketone production increases markedly. Severe deficiency may cause ketoacidosis. Insulin normally suppresses ketogenesis.

22. Glucagon Excess
Glucagon excess stimulates fatty acid oxidation and ketone production. It promotes hepatic energy mobilization. Ketogenesis increases during fasting. Elevated glucagon contributes to diabetic ketoacidosis. It acts opposite to insulin.

23. Oxaloacetate Depletion
Oxaloacetate depletion occurs when gluconeogenesis consumes oxaloacetate. Acetyl-CoA cannot efficiently enter the citric acid cycle. Excess acetyl-CoA is converted into ketone bodies. Ketogenesis therefore increases. This is a key mechanism during fasting.

24. Metabolic Acidosis
Metabolic acidosis develops when ketone bodies accumulate excessively. Blood pH decreases. Severe cases impair organ function. Diabetic ketoacidosis is a common cause. Prompt correction is essential.

25. Ketone Utilization
Ketone utilization is the conversion of ketone bodies into energy. Peripheral tissues perform this process efficiently. Acetyl-CoA enters the citric acid cycle. ATP production results. Ketone utilization supports survival during fasting.

Chapter 51: Fatty Acid Synthesis

01. Lipogenesis
Lipogenesis is the metabolic process by which fatty acids are synthesized from excess carbohydrates and other nutrients. It occurs mainly in the liver and adipose tissue. The process stores excess energy in the form of fat. Insulin strongly stimulates lipogenesis. It is important for long-term energy storage.

02. Fatty Acid Synthesis
Fatty acid synthesis is the formation of fatty acids from acetyl-CoA units. It occurs primarily in the cytosol of cells. NADPH provides the reducing power required for synthesis. The major product is palmitate. This pathway is active in the fed state.

03. Acetyl-CoA
Acetyl-CoA serves as the starting substrate for fatty acid synthesis. It is generated from carbohydrate and amino acid metabolism. Since it cannot directly cross mitochondrial membranes, it is transported as citrate. It provides carbon atoms for growing fatty acid chains. Acetyl-CoA is a central metabolic intermediate.

04. Malonyl-CoA
Malonyl-CoA is the immediate donor of two-carbon units during fatty acid synthesis. It is produced from acetyl-CoA by acetyl-CoA carboxylase. This reaction is the committed step of lipogenesis. Malonyl-CoA also inhibits fatty acid oxidation. It regulates lipid metabolism effectively.

05. Acetyl-CoA Carboxylase
Acetyl-CoA carboxylase is the rate-limiting enzyme of fatty acid synthesis. It converts acetyl-CoA into malonyl-CoA. Biotin acts as its cofactor. Insulin activates the enzyme, while glucagon inhibits it. It controls the overall rate of lipogenesis.

06. Fatty Acid Synthase
Fatty acid synthase is a multifunctional enzyme complex responsible for fatty acid chain formation. It sequentially adds two-carbon units to the growing chain. NADPH supplies reducing equivalents. The major end product is palmitate. It is essential for de novo fatty acid synthesis.

07. Biotin
Biotin is a water-soluble vitamin that functions as a coenzyme in carboxylation reactions. It is required by acetyl-CoA carboxylase. Biotin helps transfer carbon dioxide during malonyl-CoA formation. Deficiency can impair lipid synthesis. It is important for normal metabolism.

08. Citrate Shuttle
The citrate shuttle transports acetyl-CoA equivalents from mitochondria to the cytosol. Citrate carries acetyl groups across the mitochondrial membrane. Cytosolic enzymes regenerate acetyl-CoA from citrate. This mechanism supplies substrate for lipogenesis. It links carbohydrate and lipid metabolism.

09. NADPH
NADPH provides reducing power for fatty acid synthesis. It is generated mainly by the pentose phosphate pathway. Each elongation cycle requires NADPH. Without NADPH, fatty acid synthesis cannot proceed efficiently. It is essential for anabolic reactions.

10. Pentose Phosphate Pathway
The pentose phosphate pathway generates NADPH and ribose sugars. NADPH produced by this pathway supports fatty acid synthesis. It also contributes to antioxidant defense. The pathway operates in the cytosol. It is important in metabolically active tissues.

11. Palmitate
Palmitate is the primary product of fatty acid synthesis. It contains sixteen carbon atoms. Further modifications produce other fatty acids. Palmitate serves as a precursor for complex lipids. It is widely distributed in the body.

12. Elongation
Elongation is the process of increasing fatty acid chain length beyond sixteen carbons. It occurs mainly in the endoplasmic reticulum. Additional carbon units are added to palmitate. Longer fatty acids are required for various cellular functions. This process expands lipid diversity.

13. Desaturation
Desaturation introduces double bonds into fatty acid chains. Specific desaturase enzymes catalyze the reaction. Unsaturated fatty acids improve membrane fluidity. The process occurs primarily in the endoplasmic reticulum. It is important for lipid function.

14. Cytosol
The cytosol is the intracellular fluid where fatty acid synthesis occurs. Enzymes of lipogenesis are located here. Substrates and cofactors interact efficiently in this compartment. Cytosolic metabolism supports energy storage. It is a major site of anabolic reactions.

15. Lipogenic Enzyme
Lipogenic enzymes are enzymes involved in fatty acid synthesis. Examples include acetyl-CoA carboxylase and fatty acid synthase. Their activity increases after carbohydrate-rich meals. Hormonal regulation influences their expression. They coordinate lipid biosynthesis.

16. Insulin Regulation
Insulin stimulates fatty acid synthesis by activating lipogenic enzymes. It promotes glucose uptake and energy storage. Lipogenesis increases in the fed state. Insulin suppresses fatty acid breakdown simultaneously. It is the major anabolic hormone.

17. Citrate Activation
Citrate activation refers to the stimulatory effect of citrate on acetyl-CoA carboxylase. High citrate levels indicate energy abundance. The enzyme becomes more active under these conditions. Fatty acid synthesis subsequently increases. Citrate acts as an important metabolic signal.

18. Malonyl-CoA Formation
Malonyl-CoA formation is the committed step in fatty acid synthesis. Acetyl-CoA carboxylase catalyzes this reaction. ATP and biotin are required. The product serves as the carbon donor for chain elongation. Regulation occurs at this step.

19. Lipid Biosynthesis
Lipid biosynthesis encompasses the synthesis of fatty acids, triglycerides, phospholipids, and cholesterol. These molecules are essential for cellular structure and energy storage. Multiple enzymatic pathways participate. Hormonal control coordinates synthesis. Lipid biosynthesis is crucial for growth and repair.

20. Energy Storage
Energy storage involves conversion of excess nutrients into triglycerides. Fatty acids synthesized during lipogenesis are esterified with glycerol. Triglycerides accumulate in adipose tissue. Stored energy can be mobilized when needed. This mechanism supports long-term survival.

21. Stearic Acid
Stearic acid is an eighteen-carbon saturated fatty acid. It can be synthesized by elongation of palmitate. It serves as a component of membrane lipids. Further modification may produce unsaturated fatty acids. It contributes to lipid structure.

22. Oleic Acid
Oleic acid is a monounsaturated fatty acid derived from stearic acid. Desaturase enzymes introduce a double bond. It is abundant in dietary fats and cell membranes. Oleic acid improves membrane fluidity. It is considered metabolically beneficial.

23. Endoplasmic Reticulum
The endoplasmic reticulum participates in fatty acid elongation and desaturation. Many lipid-modifying enzymes are located here. It contributes to synthesis of membrane lipids. The organelle coordinates lipid processing. It is important in cellular metabolism.

24. Lipogenic Hormones
Lipogenic hormones stimulate fat synthesis and storage. Insulin is the most important example. These hormones increase expression of lipogenic enzymes. Energy is directed toward storage rather than oxidation. They help maintain metabolic balance.

25. De Novo Lipogenesis
De novo lipogenesis is the synthesis of fatty acids from non-lipid precursors. Excess carbohydrates are commonly converted into fat. The pathway is most active after meals. It contributes to triglyceride accumulation. Excessive activity may promote obesity.

Chapter 52: Triglyceride Metabolism

01. Triglyceride
Triglycerides are the major storage form of fat in the body. They consist of glycerol and three fatty acids. Triglycerides provide a concentrated energy source. They are stored mainly in adipose tissue. Their metabolism is essential for energy homeostasis.

02. Triacylglycerol
Triacylglycerol is another name for triglyceride. It serves as the principal energy reserve of the body. Excess dietary energy is stored in this form. Mobilization occurs during fasting and exercise. It is highly energy dense.

03. Glycerol
Glycerol is a three-carbon alcohol that forms the backbone of triglycerides. It is released during lipolysis. The liver can convert glycerol into glucose. It participates in energy metabolism. Glycerol links lipid and carbohydrate pathways.

04. Fatty Acid Esterification
Fatty acid esterification is the formation of triglycerides from glycerol and fatty acids. Ester bonds are created during this process. It occurs mainly in the liver and adipose tissue. Esterification promotes energy storage. The reaction is stimulated by insulin.

05. Lipogenesis
Lipogenesis in triglyceride metabolism refers to the synthesis and storage of fat. Newly synthesized fatty acids are incorporated into triglycerides. Excess nutrients favor this process. It contributes to adipose tissue expansion. Lipogenesis stores surplus energy efficiently.

06. Lipolysis
Lipolysis is the breakdown of triglycerides into glycerol and fatty acids. It occurs primarily in adipocytes. Hormonal signals activate the process during fasting. Released fatty acids provide energy to tissues. Lipolysis is essential for fuel mobilization.

07. Hormone-Sensitive Lipase
Hormone-sensitive lipase is a key enzyme of lipolysis. It hydrolyzes stored triglycerides in adipose tissue. Catecholamines stimulate its activity. Insulin suppresses the enzyme. It regulates the release of fatty acids into circulation.

08. Adipocyte
Adipocytes are specialized fat-storing cells. They accumulate triglycerides during periods of energy excess. Lipolysis releases stored fat when energy is needed. Adipocytes also secrete regulatory hormones. They play a major role in metabolic regulation.

09. Adipose Tissue
Adipose tissue is the primary site of triglyceride storage. It functions as an energy reservoir. The tissue also acts as an endocrine organ. Hormones released from adipose tissue influence metabolism. It helps maintain energy balance.

10. Energy Reserve
Triglycerides serve as the body's largest energy reserve. They store more energy than carbohydrates or proteins. Mobilization occurs during prolonged fasting. Stored energy supports vital organ function. This reserve is crucial for survival.

11. Glycerol Kinase
Glycerol kinase converts glycerol into glycerol-3-phosphate. This reaction occurs mainly in the liver. The product can be used for triglyceride synthesis. It also participates in gluconeogenesis. The enzyme links lipid and carbohydrate metabolism.

12. Glycerol-3-Phosphate
Glycerol-3-phosphate serves as the backbone for triglyceride synthesis. It combines with fatty acids to form triglycerides. The molecule is derived from glycerol or glucose metabolism. It is essential for lipid storage. Its availability influences triglyceride formation.

13. Diglyceride
Diglyceride contains glycerol attached to two fatty acids. It is an intermediate in triglyceride synthesis and degradation. Further esterification produces triglycerides. Diglycerides also function in cell signaling. They play multiple metabolic roles.

14. Monoglyceride
Monoglycerides contain one fatty acid attached to glycerol. They are intermediates in lipid digestion and metabolism. Intestinal cells reassemble them into triglycerides. They contribute to dietary fat absorption. Their metabolism is closely regulated.

15. Ester Bond
An ester bond links fatty acids to glycerol molecules. Formation of these bonds creates triglycerides. Hydrolysis of ester bonds occurs during lipolysis. Energy storage and mobilization depend on these reactions. Ester bonds are fundamental to lipid structure.

16. Fat Storage
Fat storage is the accumulation of triglycerides within adipose tissue. It occurs when energy intake exceeds energy expenditure. Insulin promotes this process by stimulating lipid synthesis. Stored fat serves as a long-term energy reserve. Proper fat storage supports metabolic stability.

17. Mobilization of Fat
Mobilization of fat is the release of stored triglycerides from adipose tissue. Lipolysis breaks triglycerides into glycerol and fatty acids. This process increases during fasting and exercise. Hormones regulate the rate of mobilization. It ensures energy availability during nutrient deprivation.

18. Free Fatty Acid Release
Free fatty acid release occurs when triglycerides are hydrolyzed. Fatty acids enter the bloodstream bound to albumin. Peripheral tissues utilize them for energy production. Release increases during fasting and stress. It is essential for maintaining energy supply.

19. Catecholamines
Catecholamines such as epinephrine and norepinephrine stimulate lipolysis. They activate hormone-sensitive lipase through cyclic AMP pathways. Fat mobilization increases during stress and exercise. Energy substrates become readily available. Catecholamines play a major role in metabolic adaptation.

20. Insulin Action
Insulin promotes triglyceride synthesis and inhibits lipolysis. It enhances glucose uptake by adipose tissue. Fat storage increases in the fed state. Hormone-sensitive lipase activity is suppressed. Insulin is the principal anabolic regulator of fat metabolism.

21. Energy Homeostasis
Energy homeostasis is the balance between energy intake and energy expenditure. Triglyceride storage and mobilization contribute to this balance. Hormonal mechanisms coordinate metabolic responses. Proper regulation maintains body weight stability. Disruption can lead to obesity or wasting.

22. Adipokine
Adipokines are biologically active molecules secreted by adipose tissue. Examples include leptin and adiponectin. They influence appetite, insulin sensitivity, and inflammation. Adipokines act as endocrine signals. They help regulate whole-body metabolism.

23. Fat Depot
A fat depot is a site where triglycerides are stored in the body. Subcutaneous and visceral adipose tissues are major depots. These stores provide energy during fasting. Different depots have distinct metabolic properties. Excess accumulation contributes to metabolic disease.

24. Triglyceride Turnover
Triglyceride turnover refers to the continuous synthesis and breakdown of triglycerides. This dynamic process maintains energy balance. Hormonal and nutritional factors regulate turnover. Efficient turnover allows adaptation to changing metabolic needs. It is essential for lipid homeostasis.

25. Lipid Mobilization
Lipid mobilization is the movement of stored lipids into circulation for energy use. Lipolysis releases fatty acids and glycerol. Mobilized lipids are transported to target tissues. Oxidation generates ATP for cellular functions. This process is crucial during fasting.

Chapter 53: Cholesterol Metabolism

01. Cholesterol
Cholesterol is a sterol found in all animal cell membranes. It contributes to membrane structure and fluidity. Cholesterol is also a precursor of bile acids, steroid hormones, and vitamin D. Both dietary intake and endogenous synthesis supply cholesterol. Proper regulation is essential for health.

02. Cholesterogenesis
Cholesterogenesis is the synthesis of cholesterol within the body. It occurs mainly in the liver. Acetyl-CoA serves as the starting substrate. Multiple enzymatic reactions form cholesterol. This pathway ensures an adequate cholesterol supply.

03. HMG-CoA Reductase
HMG-CoA reductase is the rate-limiting enzyme of cholesterol synthesis. It converts HMG-CoA into mevalonate. The enzyme is tightly regulated by cellular cholesterol levels. Statin drugs inhibit its activity. It is a major target for lipid-lowering therapy.

04. Mevalonate Pathway
The mevalonate pathway is the biochemical route for cholesterol synthesis. It begins with acetyl-CoA and proceeds through mevalonate formation. Several intermediates are generated. The pathway ultimately produces cholesterol and other isoprenoids. It is essential for cellular metabolism.

05. Sterol
Sterols are lipid molecules characterized by a steroid nucleus and a hydroxyl group. Cholesterol is the principal sterol in humans. Sterols contribute to membrane stability. They also serve as precursors for biologically active compounds. Sterols are vital cellular components.

06. Cell Membrane
The cell membrane contains cholesterol as a structural component. Cholesterol regulates membrane fluidity and permeability. It stabilizes membrane architecture. Proper membrane function depends on adequate cholesterol content. It is essential for cellular integrity.

07. Bile Acid Synthesis
Bile acid synthesis converts cholesterol into bile acids in the liver. This pathway represents a major route of cholesterol elimination. Bile acids aid fat digestion and absorption. Enterohepatic circulation conserves these molecules efficiently. The process helps maintain cholesterol balance.

08. Steroid Hormone
Steroid hormones are synthesized from cholesterol. Examples include cortisol, aldosterone, estrogen, and testosterone. These hormones regulate numerous physiological processes. Cholesterol is therefore an essential precursor molecule. Hormone synthesis occurs mainly in endocrine glands.

09. Vitamin D Synthesis
Vitamin D synthesis begins with a cholesterol derivative in the skin. Ultraviolet light converts it into vitamin D precursors. Subsequent activation occurs in the liver and kidneys. Vitamin D regulates calcium metabolism. Cholesterol is therefore indirectly important for bone health.

10. LDL Receptor
The LDL receptor binds and internalizes LDL particles. It facilitates cholesterol uptake by cells. Receptor-mediated endocytosis maintains cholesterol homeostasis. Defects cause familial hypercholesterolemia. Proper receptor function reduces cardiovascular risk.

11. Hepatic Cholesterol
Hepatic cholesterol refers to cholesterol present within the liver. The liver synthesizes, stores, and distributes cholesterol. It also converts cholesterol into bile acids. Hepatic regulation influences plasma cholesterol levels. The liver is central to cholesterol metabolism.

12. Cholesterol Ester
Cholesterol esters are storage forms of cholesterol. A fatty acid is attached to the hydroxyl group of cholesterol. These molecules are found in lipoproteins and cells. Esterification reduces cholesterol toxicity. They serve as transport and storage forms.

13. ACAT
ACAT stands for acyl-CoA cholesterol acyltransferase. It catalyzes cholesterol ester formation within cells. Esterification allows safe cholesterol storage. ACAT helps regulate intracellular cholesterol levels. The enzyme contributes to lipid homeostasis.

14. Free Cholesterol
Free cholesterol is unesterified cholesterol present in membranes and plasma. It is biologically active and structurally important. Excess free cholesterol can be harmful to cells. Regulatory mechanisms maintain optimal concentrations. Balance between free and esterified cholesterol is essential.

15. Reverse Cholesterol Transport
Reverse cholesterol transport removes excess cholesterol from peripheral tissues. HDL particles carry cholesterol to the liver. The liver excretes cholesterol through bile. This process protects against atherosclerosis. It is a key antiatherogenic mechanism.

16. Statin
Statins are drugs that inhibit HMG-CoA reductase. They reduce endogenous cholesterol synthesis. LDL cholesterol levels decrease significantly. Statins lower cardiovascular risk. They are widely used in dyslipidemia management.

17. SREBP
SREBP stands for sterol regulatory element-binding protein. It regulates genes involved in cholesterol synthesis and uptake. Low cholesterol levels activate SREBP. Cholesterol production subsequently increases. It serves as a cellular cholesterol sensor.

18. Lipid Raft
Lipid rafts are cholesterol-rich microdomains within cell membranes. They organize signaling molecules efficiently. Membrane receptors often localize within these regions. Cholesterol is essential for their structure. Lipid rafts influence cellular communication.

19. Hypercholesterolemia
Hypercholesterolemia refers to elevated blood cholesterol levels. It increases the risk of atherosclerosis and cardiovascular disease. Genetic and environmental factors contribute. Early diagnosis improves outcomes. Treatment includes lifestyle changes and medications.

20. Sterol Regulatory Protein
Sterol regulatory proteins control genes involved in lipid metabolism. They respond to cellular cholesterol levels. These proteins coordinate synthesis and uptake pathways. Proper regulation maintains cholesterol balance. Dysregulation may cause metabolic disorders.

21. Cholesterol Homeostasis
Cholesterol homeostasis is the maintenance of normal cholesterol levels. Synthesis, absorption, transport, and excretion are balanced. Regulatory mechanisms prevent deficiency or excess. Homeostasis is vital for cellular function. Disturbance may lead to disease.

22. Biliary Excretion
Biliary excretion is the elimination of cholesterol through bile. Cholesterol leaves the body mainly by this route. Some cholesterol is converted into bile acids before excretion. This process helps regulate cholesterol balance. It is a major pathway of cholesterol removal.

23. Endogenous Cholesterol
Endogenous cholesterol is synthesized within the body. The liver is the principal site of production. It provides cholesterol for cellular needs. Dietary intake is not the sole source of cholesterol. Endogenous synthesis is carefully regulated.

24. Exogenous Cholesterol
Exogenous cholesterol is obtained from dietary sources. Animal-derived foods are major contributors. Intestinal absorption determines its availability. Dietary cholesterol influences plasma levels variably. It supplements endogenous synthesis.

25. Cholesterol Pool
The cholesterol pool represents the total cholesterol available within the body. It includes cholesterol in cells, plasma, and tissues. Continuous exchange occurs among compartments. Homeostatic mechanisms regulate pool size. Proper control is essential for health.

Chapter 54: Lipoprotein Metabolism

01. Lipoprotein
Lipoproteins are complexes of lipids and proteins that transport lipids in blood. They enable movement of water-insoluble lipids through plasma. Different classes have specialized functions. Lipoproteins maintain lipid distribution throughout the body. They are essential for lipid metabolism.

02. Chylomicron
Chylomicrons are the largest lipoproteins and transport dietary triglycerides. They are synthesized in intestinal enterocytes. After entering circulation, triglycerides are delivered to tissues. Remnants are taken up by the liver. They represent the first stage of dietary lipid transport.

03. Very Low-Density Lipoprotein (VLDL)
Very low-density lipoprotein (VLDL) is synthesized by the liver to transport endogenous triglycerides. It delivers triglycerides to peripheral tissues. Lipoprotein lipase removes triglycerides during circulation. VLDL is eventually converted into LDL. It plays a major role in triglyceride transport.

04. Intermediate-Density Lipoprotein (IDL)
Intermediate-density lipoprotein (IDL) is formed during the conversion of VLDL to LDL. It contains both cholesterol and triglycerides. Some IDL is removed by the liver. The remainder is converted into LDL. It acts as a transitional lipoprotein.

05. Low-Density Lipoprotein (LDL)
Low-density lipoprotein (LDL) is the primary carrier of cholesterol in plasma. It delivers cholesterol to peripheral tissues. Elevated LDL levels promote atherosclerosis. LDL receptors regulate its uptake. It is commonly called "bad cholesterol."

06. High-Density Lipoprotein (HDL)
High-density lipoprotein (HDL) removes excess cholesterol from tissues and transports it to the liver. This process is called reverse cholesterol transport. HDL protects against atherosclerosis. High HDL levels are generally beneficial. It is often called "good cholesterol."

07. Apolipoprotein
Apolipoproteins are protein components of lipoproteins. They stabilize lipoprotein structure and regulate metabolism. Many act as enzyme cofactors or receptor ligands. Different lipoproteins contain specific apolipoproteins. They are essential for lipid transport.

08. Apo A-I
Apo A-I is the major apolipoprotein of HDL. It activates lecithin-cholesterol acyltransferase. Apo A-I promotes reverse cholesterol transport. It contributes to HDL maturation. High levels are associated with cardiovascular protection.

09. Apo B-48
Apo B-48 is the structural protein of chylomicrons. It is synthesized in intestinal cells. The protein is essential for chylomicron assembly. It facilitates transport of dietary lipids. Without Apo B-48, chylomicron formation is impaired.

10. Apo B-100
Apo B-100 is the major structural protein of VLDL, IDL, and LDL. It serves as a ligand for LDL receptors. The protein is synthesized in the liver. It is essential for lipoprotein metabolism. Elevated Apo B-100 is associated with cardiovascular risk.

11. Apo C-II
Apo C-II is an apolipoprotein that activates lipoprotein lipase. It is transferred between lipoproteins in circulation. Activation of lipoprotein lipase promotes triglyceride hydrolysis. This process allows fatty acid delivery to tissues. Apo C-II is essential for normal triglyceride metabolism.

12. Apo E
Apo E is an apolipoprotein involved in lipoprotein remnant clearance. It acts as a ligand for hepatic receptors. Chylomicron remnants and IDL particles contain Apo E. Efficient removal depends on its presence. Genetic variants influence cardiovascular risk.

13. Lipoprotein Lipase
Lipoprotein lipase hydrolyzes triglycerides in chylomicrons and VLDL. The enzyme is attached to capillary endothelium. Released fatty acids are taken up by tissues. Apo C-II activates its activity. It plays a central role in lipid utilization.

14. Hepatic Lipase
Hepatic lipase is produced by the liver and acts on circulating lipoproteins. It hydrolyzes triglycerides and phospholipids. The enzyme contributes to HDL and LDL remodeling. Lipoprotein metabolism depends partly on its activity. It helps maintain lipid balance.

15. Lecithin-Cholesterol Acyltransferase (LCAT)
Lecithin-cholesterol acyltransferase (LCAT) is an enzyme associated with HDL particles. It converts free cholesterol into cholesterol esters. This reaction promotes HDL maturation. Cholesterol transport becomes more efficient. LCAT is essential for reverse cholesterol transport.

16. CETP
CETP stands for cholesteryl ester transfer protein. It exchanges cholesterol esters and triglycerides between lipoproteins. This process influences HDL and LDL composition. CETP affects plasma lipid profiles. It plays a role in cardiovascular risk regulation.

17. Reverse Cholesterol Transport
Reverse cholesterol transport removes excess cholesterol from peripheral tissues. HDL collects cholesterol and carries it to the liver. Cholesterol is then excreted through bile. This process protects arteries from cholesterol accumulation. It is a major antiatherogenic mechanism.

18. Lipoproteinemia
Lipoproteinemia refers to the concentration and distribution of lipoproteins in plasma. Normal levels are necessary for lipid transport. Abnormal levels may indicate metabolic disorders. Assessment helps diagnose lipid abnormalities. It is important in cardiovascular medicine.

19. Dyslipoproteinemia
Dyslipoproteinemia is an abnormality in lipoprotein concentration or composition. It may involve elevated LDL or reduced HDL. The condition increases cardiovascular risk. Genetic and environmental factors contribute. Early treatment reduces complications.

20. Lipid Transport
Lipid transport is the movement of lipids throughout the body via lipoproteins. Water-insoluble lipids require specialized carriers. Lipoproteins deliver triglycerides and cholesterol to tissues. Efficient transport supports cellular function. It is fundamental to lipid metabolism.

21. Lipoprotein Particle
A lipoprotein particle consists of lipids surrounded by apolipoproteins. The structure allows lipid transport in plasma. Different particles have distinct densities and functions. Their composition determines metabolic behavior. They are essential transport vehicles.

22. Remnant Lipoprotein
Remnant lipoproteins are partially metabolized lipoprotein particles. Examples include chylomicron remnants and IDL. They are normally removed by the liver. Excess remnants promote atherosclerosis. Efficient clearance is important for vascular health.

23. Receptor-Mediated Endocytosis
Receptor-mediated endocytosis is the uptake of lipoproteins through specific cell receptors. LDL receptors are a classic example. Bound particles enter cells in vesicles. Cholesterol is subsequently released for cellular use. This mechanism regulates cholesterol homeostasis.

24. HDL Maturation
HDL maturation is the process by which nascent HDL becomes functional mature HDL. Cholesterol uptake and esterification occur during maturation. LCAT plays a major role. Mature HDL participates in reverse cholesterol transport. This process enhances cardiovascular protection.

25. Lipid Exchange
Lipid exchange refers to the transfer of lipids between lipoproteins. CETP facilitates many of these exchanges. Redistribution affects lipoprotein composition and function. Lipid exchange contributes to metabolic regulation. It influences cardiovascular risk.

Chapter 55: Atherosclerosis

01. Atherosclerosis
Atherosclerosis is a chronic disease characterized by plaque formation in arterial walls. Lipid accumulation and inflammation are central features. Progressive narrowing reduces blood flow. Serious complications include heart attack and stroke. It is a leading cause of mortality worldwide.

02. Atheroma
An atheroma is a lipid-rich lesion within an artery wall. It contains cholesterol, inflammatory cells, and connective tissue. Atheromas enlarge over time. They contribute to arterial narrowing. Advanced lesions may rupture and cause thrombosis.

03. Plaque Formation
Plaque formation is the development of atherosclerotic lesions within arteries. Lipid deposition initiates the process. Inflammation and smooth muscle proliferation contribute to growth. Plaques gradually obstruct blood flow. Their stability influences clinical outcomes.

04. Endothelial Dysfunction
Endothelial dysfunction is an early event in atherosclerosis. The vascular endothelium loses its normal protective functions. Increased permeability allows lipid entry into the arterial wall. Inflammation becomes more prominent. Dysfunction promotes plaque development.

05. Foam Cell
Foam cells are macrophages filled with cholesterol esters. They form after uptake of oxidized LDL. Foam cells accumulate within arterial walls. Their presence contributes to fatty streak formation. They are characteristic of early atherosclerosis.

06. Fatty Streak
A fatty streak is the earliest visible lesion of atherosclerosis. It consists mainly of foam cells. Fatty streaks develop during childhood and adolescence. Some progress into advanced plaques. They represent the initial stage of atherogenesis.

07. Oxidized LDL
Oxidized LDL is LDL that has undergone oxidative modification. It is highly atherogenic. Macrophages readily take up oxidized LDL. Foam cell formation increases as a result. Oxidized LDL promotes inflammation and plaque growth.

08. Macrophage
Macrophages are immune cells involved in atherosclerotic plaque development. They ingest oxidized LDL and become foam cells. Macrophages release inflammatory mediators. These substances promote lesion progression. They play a key role in vascular inflammation.

09. Smooth Muscle Cell
Smooth muscle cells migrate from the arterial media into the intima. They proliferate and produce extracellular matrix. This contributes to fibrous plaque formation. Smooth muscle activity stabilizes some plaques. They are important in lesion progression.

10. Fibrous Plaque
A fibrous plaque is an advanced atherosclerotic lesion. It contains lipids covered by a fibrous cap. The cap separates plaque contents from blood. Stable plaques have thick fibrous caps. Plaque rupture increases clinical risk.

11. Arterial Wall
The arterial wall is the site where atherosclerotic lesions develop. Lipids accumulate within the intimal layer. Inflammatory and structural changes occur progressively. Arterial elasticity decreases over time. These changes impair blood flow.

12. Inflammation
Inflammation is a major contributor to atherosclerosis. Immune cells infiltrate arterial lesions. Cytokines promote plaque growth and instability. Chronic inflammation accelerates vascular damage. It is central to disease progression.

13. Plaque Rupture
Plaque rupture occurs when the fibrous cap breaks. Thrombogenic material becomes exposed to blood. Rapid clot formation may follow. Plaque rupture often precipitates acute cardiovascular events. It is a dangerous complication.

14. Thrombosis
Thrombosis is the formation of a blood clot within a vessel. It frequently follows plaque rupture. The clot may obstruct blood flow completely. Tissue ischemia develops downstream. Thrombosis is responsible for many acute vascular events.

15. Coronary Artery Disease
Coronary artery disease results from atherosclerosis of coronary arteries. Reduced blood flow causes myocardial ischemia. Symptoms include angina and heart attack. It is a major cardiovascular disorder. Prevention focuses on risk factor control.

16. Carotid Artery Disease
Carotid artery disease involves atherosclerotic narrowing of carotid arteries. Blood supply to the brain may be compromised. Stroke risk increases significantly. Early detection is important. Management includes lifestyle modification and medical therapy.

17. Peripheral Artery Disease
Peripheral artery disease affects arteries supplying the limbs. Atherosclerotic narrowing reduces blood flow. Patients may develop claudication. Severe cases can lead to tissue loss. It reflects systemic vascular disease.

18. Ischemia
Ischemia is inadequate blood supply to tissues. Atherosclerotic obstruction commonly causes ischemia. Oxygen delivery becomes insufficient. Tissue function is impaired. Prolonged ischemia may lead to infarction.

19. Infarction
Infarction is tissue death resulting from prolonged ischemia. Complete vascular occlusion is often responsible. Examples include myocardial infarction and cerebral infarction. Rapid treatment improves outcomes. Infarction causes permanent tissue damage.

20. Vascular Injury
Vascular injury refers to damage of blood vessel walls. Hypertension, smoking, and diabetes contribute to injury. Endothelial dysfunction frequently follows. Injury promotes atherosclerotic changes. Prevention reduces cardiovascular risk.

21. Risk Factor
A risk factor is a characteristic that increases the likelihood of disease. Major atherosclerotic risk factors include smoking, diabetes, hypertension, and dyslipidemia. Multiple factors often coexist. Risk assessment guides prevention strategies. Modification reduces disease burden.

22. Hyperlipidemia
Hyperlipidemia is the elevation of blood lipid levels. Increased LDL cholesterol is particularly important. Excess lipids accelerate plaque formation. Cardiovascular risk rises substantially. Treatment aims to normalize lipid levels.

23. Hypertension
Hypertension damages arterial walls and promotes atherosclerosis. Increased pressure accelerates endothelial dysfunction. Plaque progression becomes more rapid. Hypertension also increases cardiovascular complications. Effective control reduces vascular risk.

24. Endothelial Activation
Endothelial activation occurs when endothelial cells express inflammatory molecules. Leukocyte adhesion increases. Vascular inflammation becomes established. This process promotes atherogenesis. It is an early event in plaque development.

25. Atherogenesis
Atherogenesis is the overall process of atherosclerotic plaque formation. It involves lipid deposition, inflammation, and fibrosis. Multiple risk factors contribute to progression. The process may continue for decades. Prevention focuses on modifying underlying causes.

Chapter 56: Obesity

01. Obesity
Obesity is a chronic condition characterized by excessive body fat accumulation. It results from long-term positive energy balance. Obesity increases the risk of diabetes, hypertension, and cardiovascular disease. Both genetic and environmental factors contribute. Effective management requires lifestyle modification and medical support.

02. Overweight
Overweight refers to body weight above the recommended range for height. It often precedes obesity. Excess body weight increases metabolic risk. Assessment commonly uses body mass index. Early intervention helps prevent complications.

03. Body Mass Index (BMI)
Body mass index is a measure of weight relative to height. It is calculated as weight in kilograms divided by height squared in meters. BMI is widely used to classify overweight and obesity. It provides a simple screening tool. However, it does not directly measure body fat.

04. Adiposity
Adiposity refers to the amount of fat stored in the body. Excess adiposity is associated with metabolic disorders. Distribution of fat is also important. Visceral adiposity carries greater health risks. Assessment helps evaluate obesity severity.

05. Adipocyte
Adipocytes are specialized cells that store triglycerides. They expand in size and number during obesity. Adipocytes also secrete hormones and cytokines. These signals influence metabolism and inflammation. They are central to obesity pathophysiology.

06. Energy Balance
Energy balance is the relationship between energy intake and energy expenditure. Body weight remains stable when both are equal. Excess intake leads to weight gain. Increased expenditure promotes weight loss. Maintaining balance is essential for healthy body weight.

07. Positive Energy Balance
Positive energy balance occurs when calorie intake exceeds calorie expenditure. Excess energy is stored mainly as triglycerides. Persistent positive balance leads to obesity. Lifestyle factors commonly contribute. Long-term imbalance increases metabolic risk.

08. Leptin
Leptin is a hormone produced by adipose tissue. It signals the hypothalamus about body energy stores. Increased leptin normally suppresses appetite. Many obese individuals develop leptin resistance. This contributes to continued weight gain.

09. Ghrelin
Ghrelin is a hormone produced primarily by the stomach. It stimulates appetite and food intake. Ghrelin levels rise before meals and decrease afterward. It plays a role in energy homeostasis. Elevated ghrelin can promote overeating.

10. Adiponectin
Adiponectin is an adipokine secreted by adipose tissue. It improves insulin sensitivity and promotes fatty acid oxidation. Levels are often reduced in obesity. Higher adiponectin levels are associated with metabolic health. It has anti-inflammatory properties.

11. Appetite Regulation
Appetite regulation involves hormonal and neural mechanisms controlling food intake. Leptin, ghrelin, and hypothalamic centers play important roles. These signals balance hunger and satiety. Disruption contributes to obesity. Effective regulation supports energy homeostasis.

12. Satiety Center
The satiety center is located in the hypothalamus. It receives signals indicating sufficient food intake. Activation decreases appetite and feeding behavior. Hormones such as leptin influence its activity. Proper function helps maintain normal body weight.

13. Hypothalamus
The hypothalamus is the brain region responsible for appetite and energy regulation. It integrates hormonal and neural signals. Hunger and satiety are coordinated here. Dysfunction may contribute to obesity. It plays a central role in metabolic control.

14. Visceral Fat
Visceral fat surrounds internal abdominal organs. It is metabolically active and strongly associated with disease risk. Excess visceral fat promotes insulin resistance. Cardiovascular complications become more common. It is more harmful than subcutaneous fat.

15. Subcutaneous Fat
Subcutaneous fat is located beneath the skin. It serves as an energy reserve and insulation layer. Although excess accumulation contributes to obesity, it is generally less harmful than visceral fat. It provides mechanical protection. Distribution varies among individuals.

16. Metabolic Syndrome
Metabolic syndrome is a cluster of metabolic abnormalities. It includes central obesity, hypertension, dyslipidemia, and insulin resistance. Cardiovascular risk is significantly increased. Early recognition is important. Lifestyle intervention is the cornerstone of management.

17. Insulin Resistance
Insulin resistance occurs when tissues respond poorly to insulin. Glucose uptake decreases despite normal or elevated insulin levels. It commonly accompanies obesity. The condition predisposes to type 2 diabetes. Weight reduction improves insulin sensitivity.

18. Caloric Excess
Caloric excess occurs when energy intake consistently exceeds energy requirements. Surplus calories are stored as fat. Over time, body weight increases. Sedentary lifestyles often contribute. Prevention requires dietary and behavioral modification.

19. Weight Gain
Weight gain results from prolonged positive energy balance. Excess calories accumulate as adipose tissue. Genetic, hormonal, and environmental factors influence the process. Gradual gain may go unnoticed initially. Sustained gain increases health risks.

20. Bariatric Surgery
Bariatric surgery is a treatment option for severe obesity. Procedures reduce food intake and nutrient absorption. Significant weight loss often occurs after surgery. Metabolic improvements are common. Careful patient selection is important.

21. Childhood Obesity
Childhood obesity refers to excessive body fat accumulation in children. It increases the risk of obesity in adulthood. Metabolic and psychological complications may develop. Early intervention improves outcomes. Healthy lifestyle habits are essential.

22. Central Obesity
Central obesity is the accumulation of excess fat around the abdomen. It is closely associated with insulin resistance and cardiovascular disease. Waist circumference helps assess central obesity. It is a major component of metabolic syndrome. Reduction lowers health risks.

23. Obesogenic Environment
An obesogenic environment promotes excessive calorie intake and reduced physical activity. Easy access to high-calorie foods contributes significantly. Urban lifestyles often encourage sedentary behavior. Environmental factors influence obesity prevalence. Public health measures can reduce risk.

24. Adipokine
Adipokines are signaling molecules released by adipose tissue. They influence appetite, inflammation, and insulin sensitivity. Examples include leptin and adiponectin. Altered adipokine production occurs in obesity. They contribute to metabolic regulation.

25. Obesity Management
Obesity management includes dietary modification, physical activity, behavioral therapy, medications, and surgery. Long-term strategies are necessary for sustained success. Weight reduction improves metabolic health. Prevention is equally important. Comprehensive care yields the best outcomes.

Chapter 57: Dyslipidemias

01. Dyslipidemia
Dyslipidemia is an abnormal level of lipids or lipoproteins in the blood. It may involve elevated cholesterol, triglycerides, or both. Dyslipidemia is a major risk factor for atherosclerosis. Both genetic and acquired causes exist. Early detection is important for prevention.

02. Hyperlipidemia
Hyperlipidemia refers to elevated concentrations of lipids in plasma. Cholesterol and triglycerides may both be increased. Persistent hyperlipidemia promotes vascular disease. Lifestyle and genetic factors contribute. Treatment reduces cardiovascular risk.

03. Hypercholesterolemia
Hypercholesterolemia is the elevation of blood cholesterol levels. Increased LDL cholesterol is particularly harmful. Atherosclerotic plaque formation accelerates. Genetic disorders may cause severe forms. Dietary and pharmacological treatments are effective.

04. Hypertriglyceridemia
Hypertriglyceridemia is the elevation of plasma triglyceride levels. It may result from obesity, diabetes, or genetic disorders. Severe elevations increase pancreatitis risk. Lifestyle modification is often beneficial. Drug therapy may be required.

05. Mixed Dyslipidemia
Mixed dyslipidemia involves elevations of both cholesterol and triglycerides. It is commonly associated with metabolic syndrome. Cardiovascular risk is significantly increased. Multiple metabolic abnormalities coexist. Comprehensive treatment is necessary.

06. Familial Hypercholesterolemia
Familial hypercholesterolemia is an inherited disorder of LDL metabolism. Mutations often affect LDL receptors. Extremely high LDL levels develop early in life. Premature cardiovascular disease is common. Early treatment improves prognosis.

07. Secondary Dyslipidemia
Secondary dyslipidemia results from underlying diseases or medications. Diabetes, hypothyroidism, and kidney disease are common causes. Treating the underlying condition may improve lipid levels. Lifestyle factors also contribute. Proper evaluation is important.

08. LDL Cholesterol
LDL cholesterol is the cholesterol carried by low-density lipoproteins. Elevated levels promote atherosclerosis. LDL delivers cholesterol to peripheral tissues. It is a primary target of lipid-lowering therapy. Lower levels reduce cardiovascular risk.

09. HDL Cholesterol
HDL cholesterol is carried by high-density lipoproteins. HDL participates in reverse cholesterol transport. Higher levels are generally protective. HDL removes excess cholesterol from tissues. It is often called protective cholesterol.

10. Total Cholesterol
Total cholesterol represents the sum of cholesterol carried by all lipoproteins. It is commonly measured during lipid profiling. Elevated values may indicate cardiovascular risk. Interpretation requires consideration of LDL and HDL levels. It provides an overview of cholesterol status.

11. Triglycerides
Triglycerides are the primary storage form of fat in the body. Elevated blood levels are associated with metabolic disease. Excessive concentrations may contribute to atherosclerosis. Severe elevations can cause pancreatitis. Monitoring is important in lipid assessment.

12. Lipid Profile
A lipid profile is a laboratory test evaluating blood lipid levels. It typically includes total cholesterol, LDL, HDL, and triglycerides. The test assists cardiovascular risk assessment. Results guide treatment decisions. Regular monitoring is often recommended.

13. Apolipoprotein B
Apolipoprotein B is the major structural protein of atherogenic lipoproteins. It is present in LDL, VLDL, and IDL particles. Apo B concentration reflects the number of atherogenic particles. Elevated levels increase cardiovascular risk. Measurement may improve risk assessment.

14. Lipoprotein(a)
Lipoprotein(a) is a modified LDL particle containing apolipoprotein(a). High levels are largely genetically determined. Elevated concentrations increase cardiovascular risk. Standard lifestyle measures have limited effects. It is considered an independent risk factor.

15. Atherogenic Lipoprotein
Atherogenic lipoproteins promote plaque formation within arteries. LDL and remnant lipoproteins are major examples. These particles deposit cholesterol in vessel walls. Chronic exposure accelerates atherosclerosis. Reducing their levels improves vascular health.

16. Xanthoma
Xanthomas are cholesterol-rich deposits within the skin and tendons. They often indicate severe lipid disorders. Different forms occur in various dyslipidemias. Clinical recognition aids diagnosis. Treatment targets the underlying lipid abnormality.

17. Xanthelasma
Xanthelasma consists of yellow cholesterol deposits around the eyelids. It may occur with or without dyslipidemia. The lesions are benign but cosmetically significant. Lipid evaluation is often recommended. They may indicate underlying metabolic abnormalities.

18. Premature Atherosclerosis
Premature atherosclerosis refers to early development of vascular disease. Genetic lipid disorders are common causes. Cardiovascular events occur at younger ages. Early diagnosis and treatment are essential. Prevention strategies significantly improve outcomes.

19. Statin Therapy
Statin therapy uses HMG-CoA reductase inhibitors to lower cholesterol levels. LDL cholesterol reduction is the primary goal. Cardiovascular events decrease significantly with treatment. Statins are first-line agents for many patients. They are widely prescribed worldwide.

20. Fibrate Therapy
Fibrate therapy primarily lowers triglyceride levels. These drugs activate peroxisome proliferator-activated receptors. HDL cholesterol may increase modestly. Fibrates are useful in hypertriglyceridemia. They reduce the risk of triglyceride-related complications.

21. PCSK9 Inhibitor
PCSK9 inhibitors are monoclonal antibodies that increase LDL receptor availability. LDL cholesterol levels fall dramatically. They are used in severe hypercholesterolemia. Cardiovascular outcomes improve with therapy. These agents are highly effective lipid-lowering drugs.

22. Dysbetalipoproteinemia
Dysbetalipoproteinemia is a disorder characterized by abnormal remnant lipoprotein accumulation. Apo E abnormalities are commonly involved. Cholesterol and triglyceride levels become elevated. Premature atherosclerosis may occur. Diagnosis requires specialized testing.

23. Fredrickson Classification
The Fredrickson classification categorizes dyslipidemias according to lipoprotein abnormalities. Several phenotypic types are recognized. The system aids understanding of lipid disorders. It has historical and educational importance. Modern classifications also incorporate genetic information.

24. Lipid-Lowering Therapy
Lipid-lowering therapy includes lifestyle measures and medications. Statins, fibrates, ezetimibe, and PCSK9 inhibitors are common options. Treatment reduces atherosclerotic risk. Individualized approaches are recommended. Long-term adherence is essential.

25. Cardiovascular Risk Assessment
Cardiovascular risk assessment evaluates the likelihood of future vascular events. Lipid levels are important components of risk estimation. Other factors include age, smoking, hypertension, and diabetes. Assessment guides preventive strategies. Accurate evaluation improves patient outcomes.